Medinitaly Pharma Progress

Medinitaly Pharma Progress is an Italian pharmaceutical company headquartered in Rome, specializing in the commercialization and distribution of prescription medicines, medical devices, and dietary supplements. Founded in 2006, the company offers a diverse portfolio of products targeting therapeutic areas such as cardiovascular health, gastroenterology, dermatology, and hepatology. Key marketed products include Trinocard (a combination of ramipril, amlodipine, and atorvastatin for hypertension and hypercholesterolemia), Klostenal (beclometasone dipropionate for ulcerative colitis), and Colefel (ursodeoxycholic acid for primary biliary cholangitis and gallstones). Medinitaly Pharma Progress collaborates with contract manufacturing organizations (CMOs) like Special Product's Line S.p.A. and Bluepharma to manufacture and package its pharmaceutical products for the Italian and European markets.